Skip to main content

The biomarker advantage

The biomarker advantage webinar

Optimizing the robust genetics data available from Quest Diagnostics to provide new insights into drug development and clinical trials

DL_Inset-Image_2-resized.jpg

The biomarker advantage webinar

As therapies become increasingly personalized, biomarker data can provide essential insights throughout the pharmaceutical pipeline — from determining disease prevalence to discovering optimal trial participants to honing physician outreach efforts to monitoring safety and efficacy.

Join Andrew Goldberg, chief operating officer of HealthVerity, and Justin Niles, director, health infomatics with Quest Diagnostics for a webinar held on June 12, 2024 to learn about the breadth and scope of biomarker data readily accessible through HealthVerity Marketplace. During this webinar, we explore Quest’s comprehensive biomarker and genetic testing technologies, methodologies, and expertise. Also discussed are the variety of use cases for this powerful data type, including physician alerts to optimize provider education and outreach.

Watch this webinar to*

  • Explore the breadth and scope of biomarker data available from Quest
  • Learn how you can optimize go-to-market strategies with precision physician alerts using specific biomarker data
  • Discover how you can sync far more insightful RWD with biomarkers in combination with other healthcare data types

Watch The biomarker advantage webinar

728

* indicates required